Cytex Therapeutics, Inc. — Form C-U (Regulation Crowdfunding)
Cytex Therapeutics, Inc. of DURHAM, NC filed a Form C-U (Regulation Crowdfunding) with the SEC on 2023-01-27. Target raise $10K, up to $1.1M. Offered through StartEngine Capital, LLC.
Offering
- Filed: 2023-01-27
- Form: C-U
- Accession: 0001665160-23-000144
- Target amount: $10K
- Maximum amount: $1.1M
- Security type: Other
- Securities offered: 5,000
- Price: $2.0000
- Deadline: 2023-01-24
- Funding portal / intermediary: StartEngine Capital, LLC
- Intermediary file number: 007-00007
Issuer
- CIK: 0001943908
- Website: http://www.cytexortho.com
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2006-07-21
- Address: 2609 N. DUKE STREET, SUITE 303A, DURHAM, NC, 27704
- Employees: 8
Financials (as filed)
- Total assets (most recent): $626K
- Cash (most recent): $489K
- Revenue (most recent): $1.8M
- Revenue (prior): $1.8M
- Net income (most recent): $-23K
- Net income (prior): $40K
- Short-term debt: $145K
People (10)
| Name | Role | Location |
|---|
| David Nolan | Director | Luxembourg, N4 |
| Farshid Guilak | Board Chairman | DURHAM, NC |
| Farshid Guilak | BOARD CHAIRMAN | DURHAM, NC |
| Christine Estes | Director of Business and Finance, Secretary and Treasurer | DURHAM, NC |
| Christine Estes | SECRETARY AND TREASURER | DURHAM, NC |
| Bradley T. Estes, Ph.D. | CEO and Director | DURHAM, NC |
| Dave Nolan | Director | DURHAM, NC |
| Dave Nolan | DIRECTOR | DURHAM, NC |
| Bradley T. Estes | CEO and Director | DURHAM, NC |
| Bradley Estes | CEO and Director | DURHAM, NC |
Reg CF filing history (6)
More